This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H2N2 Hemagglutinin (HA), N-His
Product Overview
BioVenic's Recombinant Influenza A H2N2 Hemagglutinin (HA), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 28.9 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Hemagglutinin is the primary surface glycoprotein of the H2N2 Influenza A virus, famously responsible for the 1957 "Asian Flu" pandemic. It functions as a homotrimer, with each monomer cleaved into HA1 and HA2 subunits. HA1 facilitates viral attachment by binding to host alpha 2,6-linked sialic acid receptors, while HA2 undergoes a pH-dependent conformational shift to mediate membrane fusion. As a major antigen, H2 HA is a critical target for broad-spectrum neutralizing antibodies and universal vaccine research.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.